Top Markets
Coin of the day
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Rang in Aktien #33959
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Aktienkurs
$1.83
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$6.53M
Veränderung (1 Tag)
-1.61%
Veränderung (1 Jahr)
-85.57%
Land
US
Handel Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Kategorie

Dividendenrendite-Verlauf für Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Dividendenrendite (TTM) von Cadrenal Therapeutics, Inc. Common Stock (Aktienkürzel: CVKD) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Cadrenal Therapeutics, Inc. Common Stock (CVKD) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber